Case Studies & Whitepapers2025-06-27
Multiple Approaches to Address the Challenges of Oral Absorption of PROTAC Drugs Download
As a
global CDMO serving global innovative pharmaceutical companies and research
institutions, Porton has
an extensive experience in research and manufacturing services, especially in
the field of PROTAC drug development. Porton is committed to the development and
production of PROTAC oral formulations and provides customers with
comprehensive, reliable, fast, and compliant one-stop services, to meet
customers' supply chain needs and facilitating the commercial success of their
products from r
More
News
More
Case Studies & Whitepapers2026-07-30
Antibody-Oligonucleotide Conjugates: From Conjugation Strategy to Purification and Analytical Control
Antibody-Oligo Conjugate (AOC), as an innovative targeted gene therapy biopharmaceutical, effectively integrates the targeting advantages of monoclonal antibodies and the gene regulatory functions of oligonucleotides, helping address key limitations in the inherent of traditional antibody drugs and nucleic acid drugs, and showing substantial clinical
Case Studies & Whitepapers2026-06-30
FAQ: Applications of Different Synthetic Strategies for Peptide Process Development
Applications of Different Peptide Synthesis Strategies in Process Development
